Investigators compared recurrence-free survival and overall survival outcomes in patients randomly assigned to receive neoadjuvant talimogene laherparepvec (T-VEC) followed by immediate surgery or surgery alone.
Findings from patients with multiple atypical nevi and one or more dysplastic nevus were compared with findings from a control group.
“‘Trended strongly’ is code for ‘we failed to meet statistical significance,’” remarked one expert, when she was asked to scrutinize the conclusions of a recent post hoc analysis.
Among people with skin of color, ultraviolet (UV) exposure may not be an important risk factor for melanoma.
A review of available insights as to the risk for malignancies in patients prescribed disease-modifying antirheumatic treatments and targeted biologic therapies is provided.
In adolescents and young adults (AYAs), cancer has a unique epidemiological pattern and is a growing concern, with an increased rate of cancer from 1973 to 2015.
An algorithm that combines deep learning on histology slides and patient clinical data may predict immune checkpoint inhibitor response in patients with advanced melanoma.
Medicaid expansion under the ACA was associated with an increase in early-stage cancer diagnoses in the first year after expansion and a decrease in late-stage cancer diagnoses 3 years after expansion.
Significant risk factors for developing cutaneous cancer in active-duty military personnel was explored and compared with that of the general population.
For the most common cancers, cancer drug approvals between 2000 and 2016 were associated with a reduction in deaths.
